Cargando…

Clinical Impact and Cost-effectiveness of Xpert MTB/RIF Testing in Hospitalized Patients With Presumptive Pulmonary Tuberculosis in the United States

BACKGROUND. Microscopic examination of acid-fast-stained sputum smears is the current standard of care in the United States to determine airborne infection isolation (AII) of inpatients with presumptive pulmonary tuberculosis (PTB). However, nucleic acid amplification testing (NAAT) with the Xpert M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cowan, James F., Chandler, Aldine S., Kracen, Elizabeth, Park, David R., Wallis, Carolyn K., Liu, Emelline, Song, Chao, Persing, David H., Fang, Ferric C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399932/ https://www.ncbi.nlm.nih.gov/pubmed/28172666 http://dx.doi.org/10.1093/cid/ciw803

Ejemplares similares

Cost-effectiveness of Xpert(®)MTB/RIF in the diagnosis of tuberculosis: pragmatic study
por: da Silva, Suely Conceição Alves, et al.
Publicado: (2021)

Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis
por: Hanrahan, Colleen F., et al.
Publicado: (2016)

Clinical Impact of the Line Probe Assay and Xpert(®) MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial
por: Kritski, Afranio, et al.
Publicado: (2022)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Genotype(®)MTBDRplus and Xpert(®)MTB/RIF in the diagnosis of tuberculosis and resistant tuberculosis: cost analysis in a tertiary referral hospital
por: Soares, Valéria Martins, et al.
Publicado: (2020)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022)

Evaluation of stool GeneXpert MTB/RIF for the diagnosis of pulmonary tuberculosis among presumptive patients in Tanzania
por: Ngadaya, Esther, et al.
Publicado: (2020)

Comparison of Xpert MTB/RIF Ultra Results of Stool and Sputum in Children with Presumptive Tuberculosis in Southern Ethiopia
por: Babo, Yohannes, et al.
Publicado: (2023)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India
por: Sarin, Sanjay, et al.
Publicado: (2019)

Impact of Xpert MTB/RIF on Antiretroviral Therapy-Associated Tuberculosis and Mortality: A Pragmatic Randomized Controlled Trial
por: Mupfumi, L., et al.
Publicado: (2014)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa
por: Cox, Helen S., et al.
Publicado: (2015)

High Yield of Active Tuberculosis Case Finding Among HIV-Infected Patients Using Xpert MTB/RIF Testing
por: Kempker, Russell R, et al.
Publicado: (2019)

Performance of GeneXpert MTB/RIF for Diagnosing Tuberculosis Among Symptomatic Household Contacts of Index Patients in South Africa
por: Velen, Kavindhran, et al.
Publicado: (2021)

Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
por: Li, Hou-He, et al.
Publicado: (2020)

Rifampicin-resistant Mycobacterium tuberculosis by GeneXpert MTB/RIF and Associated Factors Among Presumptive Pulmonary Tuberculosis Patients in Nepal
por: Sah, Shiv Kumar, et al.
Publicado: (2020)

Surveillance of Rifampicin Resistance With GeneXpert MTB/RIF in the National Reference Laboratory for Tuberculosis at the Institut Pasteur in Bangui, 2015–2017
por: Farra, Alain, et al.
Publicado: (2019)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Oral Swab Specimens Tested With Xpert MTB/RIF Ultra Assay for Diagnosis of Pulmonary Tuberculosis in Children: A Diagnostic Accuracy Study
por: Cox, Helen, et al.
Publicado: (2022)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
por: Antel, Katherine, et al.
Publicado: (2020)

Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study
por: Wasihun, Araya Gebreyesus, et al.
Publicado: (2020)

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2014)

Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis
por: Kipiani, Maia, et al.
Publicado: (2021)

Comparison of Analytical Sensitivity (Limit of Detection) of Xpert MTB/RIF and Xpert MTB/RIF Ultra for Non-Sputum Specimens
por: Nielsen, Marisa C., et al.
Publicado: (2023)

Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2013)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

Evaluating the Diagnostic Accuracy of Xpert MTB/RIF Assay in Pulmonary Tuberculosis
por: Sharma, Surendra K, et al.
Publicado: (2015)

Tissue Xpert® MTB/RIF Assay in Peritoneal Tuberculosis: To be (Done) or Not to be (Done)
por: Dahale, Amol S, et al.
Publicado: (2019)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
por: Kumar, Suraj, et al.
Publicado: (2017)

Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF
por: Lombardi, Giulia, et al.
Publicado: (2017)

Performance of Xpert(®) MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi
por: Chikaonda, Tarsizio, et al.
Publicado: (2017)

The Role of Xpert MTB/RIF Ultra in Diagnosing Pulmonary Tuberculosis in Children
por: Schaaf, H. Simon, et al.
Publicado: (2019)

Correction to: Diagnostic accuracy of the Xpert MTB/Rif Ultra for tuberculosis adenitis
por: Antel, Katherine, et al.
Publicado: (2020)

Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
por: Haraka, Frederick, et al.
Publicado: (2021)

Clinical and CT characteristics of Xpert MTB/RIF-negative pulmonary tuberculosis
por: Lee, Han Na, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a2p9oe6pp8sgs9im5mrv5enure